Corvus Pharmaceuticals, Inc. 4
4 · Corvus Pharmaceuticals, Inc. · Filed Mar 24, 2016
Insider Transaction Report
Form 4
Verner Erik J.
V.P., Chemistry Research
Transactions
- Award
Stock Option (Right to Buy)
2016-03-22+60,000→ 60,000 totalExercise: $15.00Exp: 2026-03-22→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to one-forty-eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from March 22, 2016, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.